99mTc-rhAnnexin V-128 Imaging of Apoptosis and Cardiotoxicity in Relationship to Ventricular Function in Patients With Early Stage Breast Cancer Receiving Doxorubicin-Based Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 02 Nov 2017
At a glance
- Drugs Tc-99m annexin V 128 (Primary)
- Indications Cardiomyopathies
- Focus Diagnostic use
- Sponsors Advanced Accelerator Applications
- 26 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Apr 2018.
- 26 Oct 2017 Status changed from active, no longer recruiting to recruiting.
- 23 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Sep 2017.